This inventor holds 3 USPTO granted patents and 8 published patent applications. Top assignee: West Virginia University. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Innovations by Inventor Marc Haut
Introduction
Marc Haut is an accomplished inventor based in Morgantown, WV (US). He has made significant contributions to the field of neurodegenerative disorders and addiction treatment. With a total of 3 patents to his name, Haut's work focuses on innovative therapeutic methods that leverage advanced technologies.
Latest Patents
One of Marc Haut's latest patents is titled "Methods of improving neurodegenerative disorders by targeted delivery of therapeutic agents." This patent outlines a method for enhancing the treatment of neurodegenerative or cognitive disorders in human patients. The approach involves identifying a target site in the patient's brain affected by the disorder and delivering therapy through low intensity focused ultrasound (LiFUS) sonication. This method utilizes various imaging and physiological parameters to optimize treatment.
Another notable patent is "Neuromodulatory methods for improving addiction using multi-dimensional feedback." This invention provides methods for improving addiction in patients through the use of focused ultrasound, deep brain stimulation, and transcranial magnetic stimulation. By monitoring the patient's response, the treatment can be adjusted to enhance its effectiveness.
Career Highlights
Marc Haut is affiliated with West Virginia University, where he conducts research and develops innovative solutions for complex medical challenges. His work has garnered attention for its potential to transform treatment protocols for neurodegenerative disorders and addiction.
Collaborations
Marc collaborates with esteemed colleagues such as Victor Finomore and Ali Rezai. Their combined expertise contributes to the advancement of research in their respective fields.
Conclusion
Marc Haut's innovative patents and research at West Virginia University highlight his commitment to improving patient outcomes in neurodegenerative disorders and addiction. His contributions are paving the way for new therapeutic approaches that could significantly impact healthcare.
